Phase II clinical trial with pegylated liposomal doxorubicin (CAELYX®/Doxil®) and quality of life evaluation (EORTC QLQ-C30) in adult patients with advanced soft tissue sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS)

  1. Poveda, A.
  2. López-Pousa, A.
  3. Martín, J.
  4. García Del Muro, J.
  5. Bernabé, R.
  6. Casado, A.
  7. Balañá, C.
  8. Sanmartín, O.
  9. Menéndez, M.D.
  10. Escudero, P.
  11. Cruz, J.
  12. Belyakova, E.
  13. Menéndez, D.
  14. Buesa, J.M.
Revue:
Sarcoma

ISSN: 1357-714X,  1369-1643

Année de publication: 2005

Volumen: 9

Número: 3-4

Pages: 127-132

Type: Article

DOI: 10.1080/13577140500287024 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus